Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc

Bullboard Posts

Comment by jethro549on Nov 30, 2016 12:59pm

97 Views

Post# 25534831

RE:RE:if criminal in the past

consolidation is meaningless if the company has a good property to work or several in MKN case. Market cap is not afftected by a roll back its only affected by a company's performance. MKN succeeding or not has nothing to do with roll backs. Its what the bashers focus on to scare people into selling them at thier bid. 11 Million on the 1 cent bid. Coincidence? probably not

Bullboard Posts

Global Tungsten Market and Supply Security